← Back
Data updated: Mar 29, 2026
ALKEM LABS LTD
CardiovascularNeurologyInfectious Disease
Generics
ALKEM LABS LTD is a generic drug manufacturer focused on Cardiovascular, Neurology, Infectious Disease.
1985
Since
125
Drugs
-
Trials
1927
Approved (2yr)
Key Drugs
EZETIMIBE AND SIMVASTATIN
ezetimibe
NPC1L1 6 indications · 2017
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
chlordiazepoxide hydrochloride
4 indications · 2020
SACUBITRIL AND VALSARTAN
sacubitril
AT1 receptor 2 indications · 2024
AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE
azilsartan kamedoxomil
AT1 receptor 2 indications · 2025
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
buprenorphine hydrochloride
Kappa-opioid receptor 1 indications · 2013
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
FINGOLIMOD HYDROCHLORIDE 2026-02-24
Labeling
GABAPENTIN 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
PREGABALIN 2026-02-24
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 33%
15 drugs
Neurology 24%
11 drugs
Infectious Disease 18%
8 drugs
Immunology 13%
6 drugs
Respiratory 11%
5 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
GSK big-pharma
Infectious Disease, Respiratory, Immunology, Neurology
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Respiratory
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
AbbVie big-pharma
Immunology, Neurology, Infectious Disease
Active (70)
RIVAROXABAN AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE SACUBITRIL AND VALSARTAN LISDEXAMFETAMINE DIMESYLATE BRIVARACETAM VARENICLINE TARTRATE ESLICARBAZEPINE ACETATE DROXIDOPA FOSFOMYCIN TROMETHAMINE CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE TOLVAPTAN DABIGATRAN ETEXILATE MESYLATE MIRABEGRON FINGOLIMOD HYDROCHLORIDE TICAGRELOR ROFLUMILAST LANTHANUM CARBONATE VIGABATRIN EZETIMIBE AND SIMVASTATIN SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE DALFAMPRIDINE OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE COLCHICINE RUFINAMIDE ROSUVASTATIN CALCIUM DEFERASIROX ARIPIPRAZOLE ESOMEPRAZOLE MAGNESIUM SOLIFENACIN SUCCINATE SIROLIMUS RABEPRAZOLE SODIUM CAPECITABINE RANOLAZINE RASAGILINE MESYLATE BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE RIZATRIPTAN BENZOATE MYCOPHENOLATE SODIUM LINEZOLID ATORVASTATIN CALCIUM LAMIVUDINE TAMSULOSIN HYDROCHLORIDE LANSOPRAZOLE TACROLIMUS LEVETIRACETAM OXCARBAZEPINE VENLAFAXINE HYDROCHLORIDE LAMOTRIGINE CEFDINIR MESALAMINE TOPIRAMATE RILUZOLE CEFPODOXIME PROXETIL CEFUROXIME AXETIL FAMOTIDINE ENALAPRIL MALEATE DICLOFENAC POTASSIUM CHOLESTYRAMINE LIGHT CHOLESTYRAMINE AZATHIOPRINE TOBRAMYCIN NIFEDIPINE VANCOMYCIN HYDROCHLORIDE CARBAMAZEPINE IBUPROFEN MARINOL AMPHETAMINE SULFATE METHYLPHENIDATE HYDROCHLORIDE CEPHALEXIN ERYTHROMYCIN
Discontinued (44)
PREGABALIN GABAPENTIN MYCOPHENOLATE MOFETIL AMLODIPINE BESYLATE OLANZAPINE LIDOCAINE PRUCALOPRIDE SUCCINATE LACOSAMIDE FINASTERIDE EVEROLIMUS QUETIAPINE FUMARATE OXYCODONE HYDROCHLORIDE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN MORPHINE SULFATE TIZANIDINE HYDROCHLORIDE METFORMIN HYDROCHLORIDE TRIAMCINOLONE ACETONIDE MINOCYCLINE HYDROCHLORIDE FESOTERODINE FUMARATE FEBUXOSTAT CLOPIDOGREL BISULFATE CEFPROZIL ITRACONAZOLE HYDRALAZINE HYDROCHLORIDE METOPROLOL SUCCINATE CINACALCET HYDROCHLORIDE IBUPROFEN AND FAMOTIDINE DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE APREMILAST VALSARTAN AMLODIPINE AND OLMESARTAN MEDOXOMIL COLESEVELAM HYDROCHLORIDE DEXMETHYLPHENIDATE HYDROCHLORIDE DULOXETINE HYDROCHLORIDE BREXPIPRAZOLE CLOBAZAM DIMETHYL FUMARATE NIMODIPINE CEFIXIME CHLORTHALIDONE EZETIMIBE TEMAZEPAM AZELASTINE HYDROCHLORIDE BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Company Info
- First Approval
- 1985-05-31
- Latest
- 2026-02-23
- Applications
- 159
FDA Sponsor Names
ALKEM LABS LTDALKEM